Consumer Health in Belgium

CONSUMER HEALTH IN BELGIUM

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Executive Summary

Differing Fates for OTC Products and Other Consumer Health

Non-otc Products Also Have Their Own Constraints

Generic, Medium-sized And/or Local Manufacturers Fare Better Than Ethical Multinationals

Movement Within Distribution

Manufacturers Remain Wary of Future Legislation

Market Indicators

Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 2 Life Expectancy at Birth 2013-2018

Market Data

Table 3 Sales of Consumer Health by Category: Value 2013-2018

Table 4 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 5 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 6 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 8 Distribution of Consumer Health by Format: % Value 2013-2018

Table 9 Distribution of Consumer Health by Format and Category: % Value 2018

Table 10 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Definitions

Sources

Summary 2 Research Sources

Headlines

Prospects

Analgesics Increasingly Susceptible To the Vagaries of the Weather

Patches and Fast-acting Products Could Prevent Saturation in Topical Analgesics/anaesthetics

Dangerous Secondary Effect of Increasing Unit Price

Competitive Landscape

Further Erosion of Mainstream Brands

Active Substances Are Becoming Brand Names, Which Benefits Generics

Brands Focus on Niche Products and New Formats

Category Data

Table 12 Sales of Analgesics by Category: Value 2013-2018

Table 13 Sales of Analgesics by Category: % Value Growth 2013-2018

Table 14 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018

Table 15 NBO Company Shares of Analgesics: % Value 2014-2018

Table 16 LBN Brand Shares of Analgesics: % Value 2015-2018

Table 17 Forecast Sales of Analgesics by Category: Value 2018-2023

Table 18 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023

Headlines

Prospects

the "sleep Hormone" Should Maintain Dynamism

Virtuous Cycle of Energy and Calming Products

Fighting Stress Should Remain A Crucial Need

Competitive Landscape

Metagenics Belgium at the Head of A Dynamic Trio

Sanofi-Synthélabo Enters Category

Dynamic Brands Offer Competition To Newcomers

Category Data

Table 19 Sales of Sleep Aids: Value 2013-2018

Table 20 Sales of Sleep Aids: % Value Growth 2013-2018

Table 21 NBO Company Shares of Sleep Aids: % Value 2014-2018

Table 22 LBN Brand Shares of Sleep Aids: % Value 2015-2018

Table 23 Forecast Sales of Sleep Aids: Value 2018-2023

Table 24 Forecast Sales of Sleep Aids: % Value Growth 2018-2023

Headlines

Prospects

Increasingly Uncertain Impact of the Weather on Respiratory Infections and Sales

Switches May Have Undesirable Secondary Effects

Antihistamines/allergy Remedies (systemic) Performs Fairly Well

Competitive Landscape

Sanofi Leader As Gbo Ahead of Medicated Confectionery Players

Non-profitable Advertising and Limited Innovation

Success Story of Toularynx Continues

Category Data

Table 25 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018

Table 26 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018

Table 27 Sales of Decongestants by Category: Value 2013-2018

Table 28 Sales of Decongestants by Category: % Value Growth 2013-2018

Table 29 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018

Table 30 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018

Table 31 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023

Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023

Headlines

Prospects

Promoting Self-medication Could Be the Solution

OTC Dermatologicals Facing Competition From All Sides

Too Small To Be Profitable

Competitive Landscape

Janssen-cilag Leads But Remains Loyal To Traditional Strategies

Advertising Important Strategy for Antifungals

Similar B2c Strategies for Other Dynamic Players

Category Data

Table 33 Sales of Dermatologicals by Category: Value 2013-2018

Table 34 Sales of Dermatologicals by Category: % Value Growth 2013-2018

Table 35 NBO Company Shares of Dermatologicals: % Value 2014-2018

Table 36 LBN Brand Shares of Dermatologicals: % Value 2015-2018

Table 37 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018

Table 38 Forecast Sales of Dermatologicals by Category: Value 2018-2023

Table 39 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Headlines

Prospects

Main Growth Drivers Not As Initially Expected

Travel Remedies and Laxatives Are Steady Performers

Burden of the Past

Competitive Landscape

Janssen-cilag Retains Leadership

Gaviscon Progresses in Antacids

Local Players Often Fare Better Than Multinationals

Category Data

Table 40 Sales of Digestive Remedies by Category: Value 2013-2018

Table 41 Sales of Digestive Remedies by Category: % Value Growth 2013-2018

Table 42 NBO Company Shares of Digestive Remedies: % Value 2014-2018

Table 43 LBN Brand Shares of Digestive Remedies: % Value 2015-2018

Table 44 Forecast Sales of Digestive Remedies by Category: Value 2018-2023

Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2018-2023

Headlines

Prospects

Eye Care Players Push for Self-medication

Artificial Tears Should Fare Better Than Allergy Eye Care and "sensitive" Products

Eye Health Supplements To Remain Non-negligible Indirect Competitors

Competitive Landscape

Théa Pharma Leads Eye Care

Disparate Performance Due To Short-term Success

Testing Proves Effective Strategy

Category Data

Table 46 Sales of Eye Care by Category: Value 2013-2018

Table 47 Sales of Eye Care by Category: % Value Growth 2013-2018

Table 48 Sales of Standard Eye Care by Format: % Value 2013-2018

Table 49 Sales of Standard Eye Care by Positioning: % Value 2013-2018

Table 50 NBO Company Shares of Eye Care: % Value 2014-2018

Table 51 LBN Brand Shares of Eye Care: % Value 2015-2018

Table 52 Forecast Sales of Eye Care by Category: Value 2018-2023

Table 53 Forecast Sales of Eye Care by Category: % Value Growth 2018-2023

Headlines

Prospects

E-cigarettes Pose Serious Threat Despite Tough Local Legislation

Only New and Fast-acting Formats Have A Chance To Succeed

Belgium Not Ready To Adopt the Eur10 Pack

Competitive Landscape

Janssen-cilag Is Most Impacted by the Bleak Performance of 2018

Niquitin Manages To Rebound While Nicotinell Collapses

Limited Innovation and Focus on Tactical Advertising

Category Indicators

Table 54 Number of Smokers by Gender 2013-2018

Category Data

Table 55 Sales of NRT Smoking Cessation Aids by Category: Value 2013-2018

Table 56 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2013-2018

Table 57 Sales of NRT Gum by Flavour: % Value 2013-2018

Table 58 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2014-2018

Table 59 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2015-2018

Table 60 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023

Table 61 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023

Headlines

Prospects

More Favourable Weather During Spring and Summer Could Be A Real Ally

Specific Products Remain Limited

Continuous Price Erosion

Competitive Landscape

Beiersdorf Retains Leadership of Wound Care

3m Remains the Main Challenger in Chemists/pharmacies

Wound Care Is the Exception for Private Label

Category Data

Table 62 Sales of Wound Care by Category: Value 2013-2018

Table 63 Sales of Wound Care by Category: % Value Growth 2013-2018

Table 64 NBO Company Shares of Wound Care: % Value 2014-2018

Table 65 LBN Brand Shares of Wound Care: % Value 2015-2018

Table 66 Forecast Sales of Wound Care by Category: Value 2018-2023

Table 67 Forecast Sales of Wound Care by Category: % Value Growth 2018-2023

Headlines

Prospects

Sports Nutrition To Be in Constant Evolution

Ongoing Revolution in Distribution

New Products, Consumer Segments and Areas With Potential

Competitive Landscape

Qnt Continues To Strengthen Its Position

Mixed Results for Most Other Players

Modern Grocery Retailers and Private Label Lines Increasingly Interested

Category Data

Table 68 Sales of Sports Nutrition by Category: Value 2013-2018

Table 69 Sales of Sports Nutrition by Category: % Value Growth 2013-2018

Table 70 NBO Company Shares of Sports Nutrition: % Value 2014-2018

Table 71 LBN Brand Shares of Sports Nutrition: % Value 2015-2018

Table 72 Forecast Sales of Sports Nutrition by Category: Value 2018-2023

Table 73 Forecast Sales of Sports Nutrition by Category: % Value Growth 2018-2023

Headlines

Prospects

Players Appear To Face Pressure From Efsa

Some Products Remain Under Scrutiny

Reduced Lifecycles and Competition From Other Products

Competitive Landscape

Mixed Results for Leader Merck Consumer Healthcare

Femannose Contributes To Dynamism of Women's Health

Medium-sized and Local Players More Reactive

Category Data

Table 74 Sales of Dietary Supplements by Category: Value 2013-2018

Table 75 Sales of Dietary Supplements by Category: % Value Growth 2013-2018

Table 76 Sales of Dietary Supplements by Positioning: % Value 2013-2018

Table 77 Sales of Fish Oils/Omega Fatty Acids by Type: % Value 2013-2018

Table 78 NBO Company Shares of Dietary Supplements: % Value 2014-2018

Table 79 LBN Brand Shares of Dietary Supplements: % Value 2015-2018

Table 80 Forecast Sales of Dietary Supplements by Category: Value 2018-2023

Table 81 Forecast Sales of Dietary Supplements by Category: % Value Growth 2018-2023

Headlines

Prospects

Favourable Outlook Due To New Opportunities in Single Vitamins

No Improvement Expected Due To Disaffection for Multivitamins

Outlook for Segmented Multivitamins Darkens

Competitive Landscape

Galephar Consolidates Its Freshly Acquired Leadership

Historic Multivitamins Operators Yield Ground But Stay Afloat

Sanofi Exits Multivitamins

Category Data

Table 82 Sales of Vitamins by Category: Value 2013-2018

Table 83 Sales of Vitamins by Category: % Value Growth 2013-2018

Table 84 Sales of Multivitamins by Positioning: % Value 2013-2018

Table 85 NBO Company Shares of Vitamins: % Value 2014-2018

Table 86 LBN Brand Shares of Vitamins: % Value 2015-2018

Table 87 Forecast Sales of Vitamins by Category: Value 2018-2023

Table 88 Forecast Sales of Vitamins by Category: % Value Growth 2018-2023

Headlines

Prospects

Doubts Over Ability To Increase Sustainably

Finding Credible Natural Claims Is Difficult

Belgium Offers Less Room for Growth Than Other Countries

Competitive Landscape

Xl-s by Omega Pharma Belgium Almost Alone in Supporting Sales

Fleeting Success

Promising Launch of Elimin Turn & Go

Category Data

Table 89 Sales of Weight Management and Wellbeing by Category: Value 2013-2018

Table 90 Sales of Weight Management and Wellbeing by Category: % Value Growth 2013-2018

Table 91 NBO Company Shares of Weight Management and Wellbeing: % Value 2014-2018

Table 92 LBN Brand Shares of Weight Management and Wellbeing: % Value 2015-2018

Table 93 Forecast Sales of Weight Management and Wellbeing by Category: Value 2018-2023

Table 94 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2018-2023

Headlines

Prospects

Herbal/traditional Products To Gain in Popularity and Distribution

Persistent Interference From Efsa and Local Authorities

Impact of Lack of Ailments

Competitive Landscape

Tilman Stands Out From the Crowd

Aggressive Promotions Are An Effective Strategy

Category Data

Table 95 Sales of Herbal/Traditional Products by Category: Value 2013-2018

Table 96 Sales of Herbal/Traditional Products by Category: % Value Growth 2013-2018

Table 97 NBO Company Shares of Herbal/Traditional Products: % Value 2014-2018

Table 98 LBN Brand Shares of Herbal/Traditional Products: % Value 2015-2018

Table 99 Forecast Sales of Herbal/Traditional Products by Category: Value 2018-2023

Table 100 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2018-2023

Headlines

Prospects

Category Under Pressure and With Limited Profitability at First Sight

Paediatric Analgesics Could Be A Shelter for Branded Players

Paediatric Digestives Will Find It Difficult To Recover

Competitive Landscape

Ethical Players Notably Specialising in Analgesics Logically Dominate

Continual Limited Innovation

Medical Devices Emerge for Children

Category Data

Table 101 Sales of Paediatric Consumer Health by Category: Value 2013-2018

Table 102 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018

Table 103 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018

Table 104 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018

Table 105 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018

Table 106 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023

Table 107 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023